a significant trendP <0.0001
There was a significant trend toward better OS for early-stage patients in the entire cohort and in the CCRT group (P <0.0001 and <0.036, respectively).
There was a significant trend toward better OS for early-stage patients in the entire cohort and in the CCRT group (P <0.0001 and <0.036, respectively).
OS was better in patients with stages III–IVB treated with CCRT plus AC than in those treated with CCRT alone, although the difference did not reach statistical significance (P = 0.093) ( Figure 5A ).